Dark Forest Capital Management LP Myriad Genetics Inc Transaction History

Dark Forest Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$18.21 - $27.88 $9,177 - $14,051	504 New	504 $10,000
Q2 2022 Aug 15, 2022	SELL	$16.45 - $25.88 $5,083 - $7,996	-309 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$22.67 - $28.01 $2,085 - $2,576	-92 Reduced 22.94%	309 $8,000
Q4 2021 Feb 11, 2022	BUY	$24.13 - $32.63 $9,676 - $13,084	401 New	401 $11,000
Q3 2021 Nov 12, 2021	SELL	$29.97 - $36.66 $0 - $0	0 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$25.39 - $32.61 $0 - $0	0 New	0 $0

253

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.25B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.